Component

Motor and cognitive severity in Caribbean Parkinson disease

Species, preparation, dose and limitations are retained on linked claims.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. A 2026 adjusted comparison found worse motor and cognitive scores in Caribbean Parkinson-disease patients, 96% of whom reported Annonaceae exposure, than in mainland-France patients.

    Experimental context and source evidence
    dose
    Historical Annonaceae-fruit exposure
    duration
    Cross-sectional severity comparison
    evidence_access
    Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.
    evidence_scope
    literature_reviewed; model-specific source-derived curation
    experimental_model
    Caribbean PD group (74) and mainland-France PD group (104)
    limitations
    Exposure was nearly inseparable from population and geography; the study cannot isolate dose, plant species, or causality.
    nutrient_topic
    Graviola (Annona muricata) chapter; interacting nutrients, drugs, peptides and proteins retain their experimental settings. · Graviola / Annona muricata
    organism
    Caribbean PD group (74) and mainland-France PD group (104)
    plain_language
    A 2026 adjusted comparison found worse motor and cognitive scores in Caribbean Parkinson-disease patients, 96% of whom reported Annonaceae exposure, than in mainland-France patients.
    primary_references
    The Clinical Effect of Annonaceae Fruit Consumption on Caribbean Parkinson's Disease Severity. (2026). https://pubmed.ncbi.nlm.nih.gov/42192274/ DOI: 10.1155/bn/8897550
    route
    Observational
    tissue
    UPDRS-III and Mattis Dementia Rating Scale

    Graviola (Annona muricata): mechanism of action and interactions (2026-09-20) · lines 88–97

    Original AI-assisted source-specific curation with primary-study citations, model, exposure, route, duration, negative findings and limitations preserved. Not publisher full text. · supports · Caribbean PD group (74) and mainland-France PD group (104) · source_derived_draft · unverified_draft

    ## graviola-human-severity A 2026 adjusted comparison found worse motor and cognitive scores in Caribbean Parkinson-disease patients, 96% of whom reported Annonaceae exposure, than in mainland-France patients. Model/species: Caribbean PD group (74) and mainland-France PD group (104) Tissue/system: UPDRS-III and Mattis Dementia Rating Scale Exposure: Historical Annonaceae-fruit exposure Route: Observational Duration: Cross-sectional severity comparison Limits: Exposure was nearly inseparable from population and geography; the study cannot isolate dose, plant species, or causality. Primary reference: The Clinical Effect of Annonaceae Fruit Consumption on Caribbean Parkinson's Disease Severity. (2026). https://pubmed.ncbi.nlm.nih.gov/42192274/ DOI: 10.1155/bn/8897550 Access: Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards